Baron Wealth Management’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-3,542
Closed -$222K 307
2026
Q1
$222K Buy
3,542
+423
+14% +$33.8K 0.07% 237
2025
Q4
$297K Sell
3,119
-95
-3% -$9.31K 0.09% 174
2025
Q3
$314K Sell
3,214
-433
-12% -$44.8K 0.1% 148
2025
Q2
$392K Buy
3,647
+154
+4% +$15.6K 0.14% 109
2025
Q1
$352K Sell
3,493
-47
-1% -$4.73K 0.15% 103
2024
Q4
$316K Sell
3,540
-200
-5% -$17.6K 0.15% 115
2024
Q3
$313K Sell
3,740
-362
-9% -$28.5K 0.15% 117
2024
Q2
$316K Sell
4,102
-1,646
-29% -$120K 0.16% 100
2024
Q1
$394K Sell
5,748
-14
-0.2% -$900 0.21% 79
2023
Q4
$333K Buy
5,762
+38
+0.7% +$2.03K 0.18% 91
2023
Q3
$302K Sell
5,724
-309
-5% -$16.2K 0.19% 89
2023
Q2
$326K Buy
6,033
+128
+2% +$6.68K 0.21% 83
2023
Q1
$295K Buy
5,905
+268
+5% +$12.6K 0.21% 86
2022
Q4
$261K Buy
+5,637
New +$244K 0.2% 95

Other funds holding BSX

Baron Wealth Management's BSX Position: Q2 2026 in Review

Baron Wealth Management sold out of Boston Scientific (BSX) in Q2 2026, closing a stake of 3,542 shares — an estimated $222K sold.

Baron Wealth Management first reported a position in BSX in Q4 2022 and held it in 14 quarters. The position peaked at $394K in Q1 2024. 303 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

  • Baron Wealth Management reported no remaining Boston Scientific position as of Q2 2026 after selling out during the quarter.
  • Baron Wealth Management sold 3,542 Boston Scientific shares in Q2 2026, an estimated $222K.
  • Baron Wealth Management first reported a position in Boston Scientific in Q4 2022 and held it in 14 quarters.
  • Baron Wealth Management's Boston Scientific position peaked at $394K in Q1 2024.
  • 303 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on Baron Wealth Management's 13F filing for Q2 2026, filed 7 Jul 2026.